Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series - Wikidata - awgldk - TriplyDB

Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series

Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series

http://www.wikidata.org/entity/Q33816223

about

Non-alcoholic fatty liver disease: need for a balanced nutritional source The hepatoprotective and hypolipidemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study.Effect of Spirulina maxima on postprandial lipemia in young runners: a preliminary report Antioxidant Potential of Spirulina platensis Mitigates Oxidative Stress and Reprotoxicity Induced by Sodium Arsenite in Male Rats.Health benefits of blue-green algae: prevention of cardiovascular disease and nonalcoholic fatty liver disease.Effect of Spirulina maxima Supplementation on Calcium, Magnesium, Iron, and Zinc Status in Obese Patients with Treated Hypertension Antioxidant, Immunomodulating, and Microbial-Modulating Activities of the Sustainable and Ecofriendly Spirulina.Antioxidant bilirubin works in multiple ways to reduce risk for obesity and its health complications

P2860

Q28248994-377CA6F5-EC50-4F6C-B966-9F55DC7EA480 Q34303169-7C0AC694-CD00-47B2-9B17-F2CF2E1831B4 Q36124288-5F7B7B97-EB69-4DFB-9D3D-45D4CFE09B4D Q36533518-FCF988EF-DD7A-4D6B-8CEA-976E4CCF1E26 Q36623024-4D58D55D-DC4A-41A8-904D-A4A0816D3C5B Q37156132-0BC1136E-DAD6-4E94-8367-D3180B04123D Q37611265-6D7C2D82-C2E4-4F56-8721-312C4C6E7962 Q58558363-7C334DC1-B51E-485B-89CB-C92DD3BF77EC

P2860

Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series

http://www.wikidata.org/entity/Q33816223

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Hepatoprotective effects of Sp ...... y liver disease: a case series

@ast

Hepatoprotective effects of Sp ...... y liver disease: a case series

@en

type

label

Hepatoprotective effects of Sp ...... y liver disease: a case series

@ast

Hepatoprotective effects of Sp ...... y liver disease: a case series

@en

prefLabel

Hepatoprotective effects of Sp ...... y liver disease: a case series

@ast

Hepatoprotective effects of Sp ...... y liver disease: a case series

@en

P1433

Q33816223-5855C1F5-D8F5-4DC1-808F-A7B4AEC4804C

P1476

Q33816223-DFA6C74E-1110-41D5-871E-EB0F501778D8

P2093

Q33816223-0D094A7C-A78B-4111-BB2E-0E041F3E790A

Q33816223-996C1CA7-397B-4EC2-A86D-06810BA2E1FA

Q33816223-D1E9EA37-67A8-429B-AA36-AF076152D6E0

P2860

Q33816223-04E79B9C-75EB-4C22-90D7-70CE6430ED94

Q33816223-14CE7B7A-5D24-4365-8F31-5A409D3A7EFC

Q33816223-33E819D2-5337-4D03-A6B7-5131F9DB7032

Q33816223-3DAABA67-C9AB-41FA-9CA3-A03778250CC6

Q33816223-5020C9A1-6947-4A1C-942C-691064910916

Q33816223-697027C0-3C61-4F49-AFAB-A91F55B42266

Q33816223-830BB016-4766-419A-9904-4C7EF921CF68

Q33816223-9384D4E8-AD2B-4EA5-A9E6-B1581172477F

Q33816223-AFB58E41-F38F-459F-850A-BDCEDEB3DE24

Q33816223-DC4F34D0-B139-4DEA-B97D-41537ED236C9

P2888

Q33816223-5CBB9B25-5D5D-4CCF-A935-13B05834AB1D

P304

Q33816223-64020A03-36E6-47D1-9F88-FC06E763BD72

P31

Q33816223-52DCF34E-AE72-406F-A2EB-DB38010B98E7

P356

Q33816223-957C8A41-F5E9-42F1-92F6-BEB0A1F95E69

P407

Q33816223-C537C635-C2A1-40EA-8351-5F19D8FEF518

P478

Q33816223-C25541FD-3B24-4F79-A74F-448FD53474F4

P577

Q33816223-894145E5-7884-4B19-B977-08B4606C2773

P5875

Q33816223-7C69B9D5-A0AB-48FB-80B3-98D062BCDF43

P6179

Q33816223-E3B46B70-4F20-450E-9970-AB951F227B6A

P698

Q33816223-D5EA9FBB-A967-4D49-9744-1F90C842C66F

P932

Q33816223-1A4FE507-806D-4C8D-BC64-1F8E804EE142

P356

1752-1947-4-103

P1433

Journal of Medical Case Reports

P1476

Hepatoprotective effects of Sp ...... y liver disease: a case series

@en

P2093

Aldo Ferreira-Hermosillo

http://www.w3.org/2001/XMLSchema#string

Marco A Juarez-Oropeza

http://www.w3.org/2001/XMLSchema#string

Patricia V Torres-Duran

http://www.w3.org/2001/XMLSchema#string

P2860

Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: a preliminary report

Nutritional and therapeutic potential of Spirulina.

Pathogenesis and management issues for non-alcoholic fatty liver disease

Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.

Nonalcoholic fatty liver disease and mitochondrial dysfunction.

Liver histology according to the presence of metabolic syndrome in nonalcoholic fatty liver disease cases.

Noninvasive assessment of hepatic steatosis.

Treatment regimens for non-alcoholic fatty liver disease.

Arthrospira maxima prevents the acute fatty liver induced by the administration of simvastatin, ethanol and a hypercholesterolemic diet to mice.

Protective effect of Spirulina fusiformis on chemical-induced genotoxicity in mice.

P2888

1752-1947-4-103

P304

103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1752-1947-4-103

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43049235

http://www.w3.org/2001/XMLSchema#string

P6179

1016084486

http://www.w3.org/2001/XMLSchema#string

P698

20370930

http://www.w3.org/2001/XMLSchema#string

P932

2861069

http://www.w3.org/2001/XMLSchema#string